API man­u­fac­tur­er Cam­brex buys Ha­lo Phar­ma for $425M — ven­tur­ing in­to fin­ished dose man­u­fac­tur­ing

In an­oth­er sign of con­sol­i­da­tion in the out­sourc­ing in­dus­try — fol­low­ing Catal­ent’s ac­qui­si­tion of Ju­niper just days ago — API man­u­fac­tur­er Cam­brex an­nounced its lat­est …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER